Therapeutic implications of autophagy modulation in prostate cancer

被引：0
|
作者：
C. Giampietri
S. Petrungaro
A. Facchiano
A. Filippini
E. Ziparo
机构：
[1] Sapienza University of Rome,Istituto Pasteur
[2] Istituto Dermopatico dell’Immacolata,Fondazione Cenci Bolognetti, Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Section of Histology and Medical Embryology
[3] IDI-IRCCS,Laboratory of Vascular Pathology
来源：
Journal of Endocrinological Investigation | 2012年 / 35卷
关键词：
Prostate Cancer; LNCaP Cell; Advanced Prostate Cancer; Autophagy Inhibitor; LNCaP Human Prostate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：945 / 945
相关论文
共 50 条
  • [41] Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches
    Doldi, Valentina
    Pennati, Marzia
    Forte, Barbara
    Gandellini, Paolo
    Zaffaroni, Nadia
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (13) : 2531 - 2542
  • [42] Autophagy in Prostate Cancer and Androgen Suppression Therapy
    Ziparo, Elio
    Petrungaro, Simonetta
    Marini, Elettra Sara
    Starace, Donatella
    Conti, Silvia
    Facchiano, Antonio
    Filippini, Antonio
    Giampietri, Claudia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06): : 12090 - 12106
  • [43] Targeting Tyrosine Kinases and Autophagy in Prostate Cancer
    Kung H.-J.
    Hormones and Cancer, 2011, 2 (1): : 38 - 46
  • [44] Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
    Silva, Valdenizia R.
    Neves, Sara P.
    Santos, Luciano de S.
    Dias, Rosane B.
    Bezerra, Daniel P.
    CANCERS, 2020, 12 (11) : 1 - 36
  • [45] From Androgen Dependence to Independence in Prostate Cancer: Unraveling Therapeutic Potential and Proteomic Landscape of Hydroxychloroquine as an Autophagy Inhibitor
    Yanar, Sevinc
    Albayrak, Merve Gulsen Bal
    Kasap, Murat
    Akpinar, Gurler
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2024, 28 (05) : 246 - 255
  • [46] Divergent Modulation of Proteostasis in Prostate Cancer
    Kirmizibayrak, Petek Ballar
    Erbaykent-Tepedelen, Burcu
    Gozen, Oguz
    Erzurumlu, Yalcin
    PROTEOSTASIS AND DISEASE: FROM BASIC MECHANISMS TO CLINICS, 2020, 1233 : 117 - 151
  • [47] Prognostic role and therapeutic implications of phosphatidylinositol transfer protein cytoplasmic 1 in primary prostate cancer
    Lu, Jianming
    Fang, Yunze
    Luo, Jiexin
    Zhou, Runxin
    Zhang, Le
    Cai, Chao
    Cao, Zhengguo
    Mo, Rujun
    JOURNAL OF MENS HEALTH, 2024, 20 (11) : 136 - 146
  • [48] Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario
    Caffo, Orazio
    Veccia, Antonello
    Russo, Lucianna
    Galligioni, Enzo
    FUTURE ONCOLOGY, 2012, 8 (12) : 1585 - 1595
  • [49] The role of SRC-3 in prostate cancer progression and implications for therapeutic targeting: A systematic review
    Zakari, Suleiman
    Cleanclay, Wisdom D.
    Bella-Omunagbe, Mercy
    Zakari, Hajara
    Ogbu, Celestine O.
    Uti, Daniel Ejim
    Ogunlana, Olubanke O.
    JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2024, 12 (05): : 994 - 1007
  • [50] Antiangiogenesis therapeutic strategies in prostate cancer
    Macpherson, GR
    Ng, SSW
    Lakhani, NJ
    Price, DK
    Venitz, J
    Figg, WD
    CANCER AND METASTASIS REVIEWS, 2002, 21 (01) : 93 - 106
12345